SEC Form 4 · accession 0001415889-15-001030
Cocrystal Pharma, Inc. · COCP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey A Meckler
Director
Period of report
Mar 23, 2015
Accepted (ET)
Mar 25, 2015 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001412486
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2,F1 | $1.015 | Mar 23, 2015 | A | 1,750,000 | A | — | Mar 23, 2025 | Common Stock | 1,750,000 | 1,750,000 | D |
Explanation of responses
- F1The securities vest monthly over a period of six months in six approximately equal increments beginning on April 23, 2015, subject to continued employment on each applicable vesting date.
- F2Not applicable.